期刊
ONCOLOGIST
卷 14, 期 10, 页码 979-985出版社
ALPHAMED PRESS
DOI: 10.1634/theoncologist.2009-0079
关键词
Fibrinogen; Ovarian cancer; Prognosis; Inflammation; Plasma
类别
Introduction. To evaluate pretherapeutic plasma fibrinogen levels as a prognostic parameter in patients with epithelial ovarian cancer (EOC). Materials and Methods. In the present multicenter study, pretherapeutic plasma fibrinogen levels were evaluated in 422 patients with EOC. Plasma fibrinogen levels were correlated with clinicopathological parameters and patient survival. Results. The mean (standard deviation) pretherapeutic plasma fibrinogen level was 450.0 (150.1) mg/dl. El-evated plasma fibrinogen levels were associated with advanced tumor stage (p = .01) and the presence of a postoperative residual tumor mass (p < .001), but not with histological grade (p = .1) and histological type (p = .8). In a multivariate Cox regression model, tumor stage (p < .001 and p < .001), postoperative residual tumor mass (p = .001 and p = .008), and plasma fibrinogen level (p < .001 and p = .002), but not histological type (p = .8 and p = .2), patient age (p = .9 and p = .9), and serum cancer antigen 125 (p = 0.2 and p = 0.3) and C-reactive protein (p = .2 and p = .3) levels, were associated with disease- free and overall survival, respectively. Histological grade was associated with overall but not with disease- free survival (p = .01 and p = .8), respectively. Conclusions. Pretherapeutic plasma fibrinogen levels can be used as an independent prognostic parameter in patients with EOC. The Oncologist 2009; 14: 979-985
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据